Literature DB >> 31369408

Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study.

Cheng Wang, Qiaohui Liu, Lei Sun, Guofeng Dai.   

Abstract

: Thrombelastography (TEG) parameters and prothrombin time (PT), activated partial thromboplastin time (APTT) are compared and analysed. According to change of TEG parameters and assessment of haemostatic state of each patient, we try to explore the feasibility of individualized anticoagulant therapies. 87 people with hip or knee diseases awaiting arthroplasty were recruited. Haemoglobin levels and TEG parameters including R, K, α-angle, maximum amplitude, coagulation index were assessed in perioperative period. PT and APTT were assessed preoperatively. For 65 patients with normal TEG parameters, PT and APTT, we use tranexamic acid (TXA) to reduce blood loss during operation. As hypercoagulability group, 12 patients awaiting unilateral total knee arthroplasty with hypercoagulable state assessed by TEG parameters or risks for venous thromboembolism received daily 10-mg rivaroxaban until 24 h preoperatively and did not receive TXA during operation. All patients received intravenous administration of argatroban after 8 h postoperatively until day 3 and oral administration of rivaroxaban (10 mg) subsequently to prevent deep vein thrombosis or/and pulmonary embolism until 35 days postoperatively. TEG parameters have significant relationships with fibrinogen, platelet and APTT. The number of patients with abnormal haemostatic state assessed by TEG parameters is higher than that assessed by PT, APTT. TEG show hypercoagulability develops throughout perioperative period. There was no significant difference in haemoglobin concentration between hypercoagulability group and normal group in patients receiving unilateral total knee arthroplasty. TEG have higher sensitivity of perioperative abnormal haemostatic state than PT, APTT in primary arthroplasty. For patients with hypercoagulability, individualized anticoagulant therapies such as preoperative administration of rivaroxaban and not using TXA in operation is safe and effective.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31369408     DOI: 10.1097/MBC.0000000000000839

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Plasma D-dimer and FDP are promising biomarkers to predict perioperative fibrinolysis and bleeding following primary total joint arthroplasty: A STROBE compliant article.

Authors:  Yan Wang; Jinwei Xie; Fuxing Pei
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 2.  Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics.

Authors:  Dejing Fan; Ziyao Ouyang; Yanping Ying; Shuangxia Huang; Pinyue Tao; Xiao Pan; Shuyu Lu; Qini Pan
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

3.  Prediction Models for Prognosis of Femoral Neck-Fracture Patients 6 Months after Total Hip Arthroplasty.

Authors:  Xiaofeng Zheng; Cong Xiao; Zhuocheng Xie; Lijuan Liu; Yinhua Chen
Journal:  Int J Gen Med       Date:  2022-04-21

4.  Tourniquet use in primary total knee arthroplasty is associated with a hypercoagulable status: a prospective thromboelastography trial.

Authors:  Chao-Ran Huang; Sheng Pan; Zheng Li; Ru-Xin Ruan; Wang-Yi Jin; Xing-Chen Zhang; Yong Pang; Kai-Jin Guo; Xin Zheng
Journal:  Int Orthop       Date:  2021-06-30       Impact factor: 3.075

5.  Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis.

Authors:  Ru-Xin Ruan; Chao-Wen Bai; Le Zhang; Chao-Ran Huang; Sheng Pan; Xing-Chen Zhang; Zheng-Ya Zhu; Xin Zheng; Kai-Jin Guo
Journal:  J Orthop Surg Res       Date:  2020-11-19       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.